NCT02764606View on ClinicalTrials.gov

CANPOS: Predictive Biomarkers of Tumor Progression in Non-small Cell Lung Cancer

RecruitingOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Non-small Cell Lung Cancer

Interventions

BIOLOGICAL

Serum and plasma samples

Serum and plasma are collected at time of diagnosis, after surgery, and at time of progression to evaluate the value of new serum markers to predict the occurrence of metastases.

Trial Locations (1)

69500

RECRUITING

Hospices Civils de Lyon / Hôpital Neurologique Pierre Wertheimer, Bron

All Listed Sponsors

lead

Hospices Civils de Lyon

OTHER

NCT02764606 - CANPOS: Predictive Biomarkers of Tumor Progression in Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter